Suppr超能文献

小型猪角膜移植的新模型:免疫抑制治疗的疗效

A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.

作者信息

Tavandzi Urania, Procházka Radek, Usvald Dusan, Hlucílová Jana, Vitásková Martina, Motlík Jan, Vítová Andrea, Filipec Martin, Forrester John V, Holán Vladimír

机构信息

Institute of Molecular Genetics, Academy of Sciences, Prague, Czech Republic.

出版信息

Transplantation. 2007 May 27;83(10):1401-3. doi: 10.1097/01.tp.0000261711.08833.a1.

Abstract

Corneal allograft rejection is frequently studied in small rodent or rabbit models. To study mechanisms of rejection in a model that more closely mimics transplantation in humans, we performed orthotopic corneal transplantation in the miniature pig using a 7-mm diameter donor graft. Four groups of recipients were studied: 1) untreated naive, 2) untreated vascularized (high risk), 3) high-risk grafts treated by topical application of prednisolone, or 4) high-risk grafts treated with a combined systemic immunosuppression regime of oral prednisone, cyclosporine A, and mycophenolate mofetil. Both the clinical features and histological assessment of corneal graft rejection showed close similarities to graft rejection in humans. Interestingly, preliminary results indicated that topical steroid treatment was superior to systemic immunosuppression in significantly promoting graft survival. Thus, corneal transplantation in the pig represents an animal model most closely resembling corneal grafting in humans, and offers possibilities for testing various clinically applicable immunosuppressive treatments.

摘要

角膜同种异体移植排斥反应通常在小型啮齿动物或兔模型中进行研究。为了在更接近人类移植的模型中研究排斥反应机制,我们使用直径7毫米的供体移植物在小型猪中进行了原位角膜移植。研究了四组受体:1)未治疗的未致敏组,2)未治疗的血管化(高风险)组,3)局部应用泼尼松龙治疗的高风险移植物组,或4)采用口服泼尼松、环孢素A和霉酚酸酯联合全身免疫抑制方案治疗的高风险移植物组。角膜移植排斥反应的临床特征和组织学评估均显示与人类的移植物排斥反应极为相似。有趣的是,初步结果表明局部类固醇治疗在显著提高移植物存活率方面优于全身免疫抑制。因此,猪的角膜移植代表了最接近人类角膜移植的动物模型,并为测试各种临床适用的免疫抑制治疗提供了可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验